• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    US Medically prescribed apps Market

    ID: MRFR/HCIT/18431-HCR
    100 Pages
    Garvit Vyas
    September 2025

    US Medically Prescribed Apps Market Research Report By Type (wellness management app, treatment management app, disease management app, women health pregnancy app, disease-specific app, others), By Device (personal digital assistant, tablet, computer, smartphone, others), By Operating System (android, windows, ios system, others) and By Application (diabetic management, multi-parameter tracker, cardiac monitoring, others) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Medically prescribed apps Market Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    US Medically prescribed apps Market Summary

    The US Medically Prescribed Apps market is projected to experience substantial growth from 4.5 USD Billion in 2024 to 25.2 USD Billion by 2035.

    Key Market Trends & Highlights

    US Medically Prescribed Apps Key Trends and Highlights

    • The market is expected to grow at a compound annual growth rate of 16.95 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 25.2 USD Billion, indicating a robust expansion.
    • In 2024, the market is valued at 4.5 USD Billion, reflecting the increasing integration of technology in healthcare.
    • Growing adoption of mobile health applications due to the rising demand for personalized healthcare is a major market driver.

    Market Size & Forecast

    2024 Market Size 4.5 (USD Billion)
    2035 Market Size 25.2 (USD Billion)
    CAGR (2025-2035) 16.95%

    Major Players

    Livongo, Epic Systems, Zebra Medical Vision, Medtronic, IBM, Johnson and Johnson, Fitbit, Cerner, Sharecare, Omada Health, Samsung, Tactio Health, Apple, Novartis

    US Medically prescribed apps Market Trends

    The US Medically Prescribed Apps Market is witnessing significant growth driven by several key market drivers. One primary driver is the increasing adoption of mobile health technologies among healthcare providers and patients, fostering better access to medical care. The rise of chronic diseases has led to the demand for effective monitoring and management tools, which is further supported by advancements in smartphone technology that allow users to track their health metrics easily.

    Moreover, regulatory support from government agencies like the FDA, which has established clear guidelines for mobile health applications, encourages the development of new apps, ensuring patient safety and efficacy. There are ample opportunities to be explored in this market, particularly as healthcare providers seek innovative solutions to enhance patient engagement and compliance with treatment plans. Collaborations between tech companies, healthcare professionals, and academic institutions can yield groundbreaking apps that cater to niche medical needs, providing tailored experiences for users.

    Additionally, as telehealth continues to evolve in the US, integrating medically prescribed apps with telemedicine services can maximize patient outcomes and streamline healthcare processes. Recent trends indicate a move towards personalization in the development of medically prescribed apps, where algorithms can adapt based on individual patient data, thus improving treatment adherence. Furthermore, there is a growing emphasis on mental health, with a variety of apps emerging to support psychological well-being, reflecting a broader recognition of mental health's importance within the healthcare system.

    The US healthcare landscape is progressively shifting to integrate these technologies as standard practice, with a growing body of research and data supporting their efficacy in clinical outcomes.

    Market Segment Insights

    Medically Prescribed Apps Market Type Insights

    The US Medically Prescribed Apps Market is experiencing substantial growth across various types, reflecting the shift towards digital health solutions. As healthcare continues to evolve, the emphasis on effective wellness management apps signifies a growing priority for preventive care, aiming to enhance individual health and lifestyle choices. Treatment management apps are also gaining traction, as they are designed to assist patients in adhering to prescribed treatments and medications, thus improving overall health outcomes.

    The importance of disease management apps cannot be overstated, as they empower patients with chronic conditions to take control of their health through real-time data tracking and personalized care plans, facilitating better communication with healthcare providers. Women health pregnancy apps highlight the crucial role of empowering expectant mothers with information and resources tailored to their unique needs, aiding in prenatal care and wellness. Meanwhile, disease-specific apps cater to niche health issues, providing users with specialized information and management tools that address their specific medical conditions.

    The "others" category captures the diverse range of innovative applications emerging in the market, showcasing the versatility and adaptability of digital health solutions.

    The increasing adoption of smartphones and wearable technology in the US is a driving force behind this market segment's growth, with consumers seeking convenient ways to manage their health. Furthermore, the integration of artificial intelligence and machine learning into these apps is creating advanced functionalities, which enhance user experience and promote engagement. The promise of improved health outcomes and reduced healthcare costs positions the US Medically Prescribed Apps Market as a significant player in the broader healthcare landscape, highlighting the increasing reliance on technology to support medical care through various types of applications.

    The rising awareness and acceptance of telehealth are also boosting the adoption of medically prescribed apps, reflecting an ongoing trend where patients are more willing to engage with technology to manage their health effectively. As the demand for personalized healthcare options intensifies, the growth and diversification of the US Medically Prescribed Apps Market will likely continue, driven by the continuous development of innovative solutions tailored to meet the unique health needs of American consumers.

    Medically Prescribed Apps Market Device Insights

    The Device segment of the US Medically Prescribed Apps Market is integral to delivering healthcare solutions efficiently. This segment encompasses various devices including personal digital assistants, tablets, computers, smartphones, and others, each playing a distinct role in the healthcare landscape. Among these, smartphones hold a prominent position due to their widespread use and accessibility, offering patients easy access to prescribed medical applications. Tablets also contribute significantly, particularly in clinical settings where larger screens enhance usability for healthcare professionals.

    Personal digital assistants and computers remain vital as they provide specialized applications for data management and patient monitoring. The proliferation of these devices is driven by increasing smartphone penetration in the US and the rising adoption of telehealth services, which facilitate remote patient management and engagement. However, challenges such as data security, regulatory compliance, and integrating with existing healthcare systems need to be addressed. The growth in digital health solutions presents opportunities for innovation in device usability and interoperability, underscoring the importance of this segment in enhancing patient outcomes and streamlining healthcare delivery.

    As demand for medically prescribed applications rises, the Device segment is expected to play a crucial role in shaping the future of the US Medically Prescribed Apps Market.

    Medically Prescribed Apps Market Operating System Insights

    The Operating System segment in the US Medically Prescribed Apps Market plays a crucial role in determining the accessibility and functionality of health applications. Various operating systems, including Android, iOS, Windows, and others, provide specific advantages and feature sets that cater to diverse user needs. Android dominates the market owing to its extensive user base and flexibility, allowing healthcare providers to deploy applications tailored to individual patient needs. iOS, on the other hand, is widely recognized for its strong security features and seamless integration with Apple devices, making it a popular choice among healthcare professionals focused on data privacy.

    Windows offers robust computing power and is often preferred in clinical settings where larger screens enhance user experience. Additionally, other operating systems also hold a significant niche by catering to specialized applications, particularly in telehealth and remote patient monitoring. As the landscape evolves with more digital health initiatives, understanding the US Medically Prescribed Apps Market segmentation across these operating systems is vital to harnessing opportunities for innovation and growth in the healthcare technology sector.

    Medically Prescribed Apps Market Application Insights

    The US Medically Prescribed Apps Market focuses significantly on applications that support various health conditions. The diabetic management segment plays a crucial role in helping patients monitor and manage their blood glucose levels, diet, and medication, addressing the increasing prevalence of diabetes in the US. Meanwhile, multi-parameter trackers are gaining traction due to their ability to consolidate numerous health metrics into one app, promoting preventive healthcare and improving patient engagement. Cardiac monitoring applications are vital for individuals with heart conditions, offering real-time data and facilitating timely interventions, which directly contributes to better health outcomes.

    Each of these applications highlights the importance of technology in managing chronic diseases, emphasizing trends like remote patient monitoring and personalized health insights. The growing integration of artificial intelligence within these applications is anticipated to enhance user experience and healthcare delivery significantly. Opportunities also lie in expanding functionalities to further align with regulatory requirements and patient needs, making the US Medically Prescribed Apps Market an evolving landscape with vast potential for growth and improvement in healthcare delivery.

    Get more detailed insights about US Medically prescribed apps Market Research Report — Global Forecast till 2035

    Key Players and Competitive Insights

    The US Medically Prescribed Apps Market is characterized by rapid growth and innovation, driven by advancements in technology and an increasing focus on patient-centered healthcare solutions. Companies operating in this market are navigating a landscape that is not only competitive but also continuously evolving. With the integration of artificial intelligence, data analytics, and mobile technology, these companies are working to enhance patient engagement, improve health outcomes, and reduce costs for both providers and patients.

    The competitive dynamics are shaped by factors such as regulatory compliance, reimbursement policies, and partnerships with healthcare providers, making it essential for players in this market to stay agile and responsive to changes.

    Livongo has established a strong position in the US Medically Prescribed Apps Market, focusing predominantly on providing digital health solutions for chronic conditions. The company's strength lies in its ability to offer personalized insights and coaching, leveraging data collected from various sources. Livongo’s approach integrates behavioral health support with chronic condition management, creating a holistic platform that engages users actively in their healthcare journeys. The company has effectively tapped into partnerships with major employers and health plans, enhancing its market presence and accessibility to a broader audience.

    Livongo’s emphasis on user-centric design and proactive care management underscores its competitive advantage, catering specifically to the needs of patients managing chronic illnesses while also improving the overall efficiency of healthcare delivery.

    Epic Systems plays a significant role in the US Medically Prescribed Apps Market, delivering comprehensive electronic health records and associated applications that facilitate interoperability among healthcare systems. Known for its robust suite of software solutions tailored for hospitals and healthcare organizations, Epic Systems has developed key products that include patient engagement tools, telehealth platforms, and data analytics capabilities. The company’s market presence is bolstered by a myriad of partnerships and collaborations with healthcare institutions, allowing it to maintain a competitive edge.

    Epic's strengths include its large user base, comprehensive service offerings, and continuous innovation to meet the demands of an evolving digital health ecosystem. The company has also engaged in strategic mergers and acquisitions, enhancing its technological capabilities and market reach, reinforcing its position as a leader in the highly competitive landscape of medically prescribed applications in the United States.

    Key Companies in the US Medically prescribed apps Market market include

    Industry Developments

    In the US Medically Prescribed Apps Market, significant developments have emerged, particularly with Livongo's integration into Teladoc Health, enhancing their digital health offerings, which was confirmed in October 2020. Epic Systems has continued to expand its interoperability capabilities, making strides in patient data accessibility. Zebra Medical Vision has garnered attention for their AI-driven diagnostic solutions, gaining traction among healthcare providers. Medtronic announced a partnership with IBM Watson Health in March 2022, focusing on data analytics to advance chronic disease management.

    Johnson and Johnson’s acquisition of Auris Health in February 2019, along with Fitbit’s ongoing enhancements in health tracking technology, exemplifies a growing investment in digital health innovations.

    Cerner has also expanded its systems to support remote patient monitoring, significantly impacting care delivery. In December 2022, Omada Health partnered with Samsung to launch a digital health program aimed at chronic disease intervention. The current market valuation reflects robust growth driven by an increased demand for remote health solutions, a trend accelerated by the COVID-19 pandemic, highlighting the importance of integrating technology within traditional healthcare frameworks to improve patient outcomes.

    Market Segmentation

    Medically Prescribed Apps Market Type Outlook

    • wellness management app
    • treatment management app
    • disease management app
    • women health pregnancy app
    • disease-specific app
    • others

    Medically Prescribed Apps Market Device Outlook

    • personal digital assistant
    • tablet
    • computer
    • smartphone
    • others

    Medically Prescribed Apps Market Application Outlook

    • diabetic management
    • multi-parameter tracker
    • cardiac monitoring
    • others

    Medically Prescribed Apps Market Operating System Outlook

    • android
    • windows
    • ios system
    • others

    Report Scope

    Report Scope:
    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 3.64(USD Billion)
    MARKET SIZE 2024 4.5(USD Billion)
    MARKET SIZE 2035 25.2(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 16.955% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Billion
    KEY COMPANIES PROFILED Livongo, Epic Systems, Zebra Medical Vision, Medtronic, IBM, Johnson and Johnson, Fitbit, Cerner, Sharecare, Omada Health, Samsung, Tactio Health, Apple, Novartis
    SEGMENTS COVERED Type, Device, Operating System, Application
    KEY MARKET OPPORTUNITIES Increased chronic disease management apps, Telehealth integration expansion, Patient adherence monitoring solutions, Mental health support applications, Regulatory support for app development
    KEY MARKET DYNAMICS increased chronic disease management, regulatory approval challenges, growing patient engagement, healthcare reimbursement changes, technological integration in healthcare
    COUNTRIES COVERED US

    FAQs

    What is the projected market size of the US Medically Prescribed Apps Market by 2035?

    The US Medically Prescribed Apps Market is expected to be valued at 25.2 USD Billion by 2035.

    What was the market size of the US Medically Prescribed Apps Market in 2024?

    In 2024, the US Medically Prescribed Apps Market is projected to be valued at 4.5 USD Billion.

    What is the expected CAGR for the US Medically Prescribed Apps Market from 2025 to 2035?

    The expected CAGR for the US Medically Prescribed Apps Market from 2025 to 2035 is 16.955%.

    Which segment of the US Medically Prescribed Apps Market is anticipated to grow the largest by 2035?

    The wellness management app segment is anticipated to grow significantly, reaching approximately 6.865 USD Billion by 2035.

    What is the estimated value of the treatment management app segment in 2024?

    The treatment management app segment is estimated to be valued at 0.833 USD Billion in 2024.

    Who are the major players in the US Medically Prescribed Apps Market?

    Major players in the market include companies like Livongo, Epic Systems, and Medtronic.

    How much is the disease management app market expected to be valued at in 2035?

    The disease management app market is expected to be valued at 5.654 USD Billion by 2035.

    What growth opportunities are expected for the women health pregnancy app segment?

    The women health pregnancy app segment is expected to witness considerable growth, reaching around 3.635 USD Billion by 2035.

    What are the prospects for the disease-specific app segment by 2035?

    The disease-specific app segment is projected to grow to 4.604 USD Billion by 2035.

    What is the market outlook for the US Medically Prescribed Apps Market in light of technological advancements?

    The market outlook remains positive as technological advancements drive growth and innovation in the sector.

    US Medically prescribed apps Market Research Report — Global Forecast till 2035 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Stories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study
    Chemicals and Materials